CM
CM Management’s Rigel Pharmaceuticals RIGL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.68M | Hold |
250,000
| – | – | 4.26% | 3 |
|
|
2025
Q1 | $4.5M | Buy |
250,000
+7,500
| +3% | +$135K | 4.52% | 4 |
|
|
2024
Q4 | $4.08M | Sell |
242,500
-47,500
| -16% | -$799K | 3.64% | 7 |
|
|
2024
Q3 | $4.69M | Buy |
+290,000
| New | +$4.69M | 3.74% | 5 |
|
|
2024
Q2 | – | Sell |
-2,000,000
| Closed | -$2.96M | – | 68 |
|
|
2024
Q1 | $2.96M | Buy |
2,000,000
+300,000
| +18% | +$444K | 2.49% | 13 |
|
|
2023
Q4 | $2.47M | Buy |
1,700,000
+200,000
| +13% | +$290K | 1.98% | 15 |
|
|
2023
Q3 | $1.62M | Hold |
1,500,000
| – | – | 1.72% | 18 |
|
|
2023
Q2 | $1.94M | Hold |
1,500,000
| – | – | 1.89% | 17 |
|
|
2023
Q1 | $1.98M | Hold |
1,500,000
| – | – | 2.35% | 12 |
|
|
2022
Q4 | $2.25M | Buy |
1,500,000
+200,000
| +15% | +$300K | 2.69% | 14 |
|
|
2022
Q3 | $1.53M | Hold |
1,300,000
| – | – | 1.71% | 20 |
|
|
2022
Q2 | $1.47M | Buy |
1,300,000
+525,000
| +68% | +$593K | 1.56% | 24 |
|
|
2022
Q1 | $2.32M | Hold |
775,000
| – | – | 1.95% | 16 |
|
|
2021
Q4 | $2.05M | Buy |
775,000
+25,000
| +3% | +$66.3K | 1.55% | 16 |
|
|
2021
Q3 | $2.72M | Hold |
750,000
| – | – | 2.03% | 12 |
|
|
2021
Q2 | $3.26M | Buy |
750,000
+250,000
| +50% | +$1.09M | 2.35% | 10 |
|
|
2021
Q1 | $1.71M | Buy |
500,000
+100,000
| +25% | +$342K | 1.27% | 23 |
|
|
2020
Q4 | $1.4M | Buy |
+400,000
| New | +$1.4M | 1.3% | 26 |
|